# Korro Bio, Inc. (KRRO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Korro Bio, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/KRRO/mda/fy2025/): filed 2026-03-12; accession 0001193125-26-104156 (https://www.sec.gov/Archives/edgar/data/1703647/000119312526104156/krro-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/KRRO/mda/fy2024/): filed 2025-03-18; accession 0000950170-25-040759 (https://www.sec.gov/Archives/edgar/data/1703647/000095017025040759/krro-20241231.htm)
- [FY 2023 MD&A](/company/KRRO/mda/fy2023/): filed 2024-03-26; accession 0000950170-24-036396 (https://www.sec.gov/Archives/edgar/data/1703647/000095017024036396/krro-20231231.htm)
- [FY 2022 MD&A](/company/KRRO/mda/fy2022/): filed 2023-03-10; accession 0000950170-23-007140 (https://www.sec.gov/Archives/edgar/data/1703647/000095017023007140/freq-20221231.htm)
- [FY 2021 MD&A](/company/KRRO/mda/fy2021/): filed 2022-03-15; accession 0000950170-22-003655 (https://www.sec.gov/Archives/edgar/data/1703647/000095017022003655/freq-20211231.htm)

Back to /company/KRRO/